dc.contributor.author | Casadio, M. | |
dc.contributor.author | Cardinale, V. | |
dc.contributor.author | Klümpen, H.-J. | |
dc.contributor.author | Morement, H. | |
dc.contributor.author | Lacasta, Adelaida | |
dc.contributor.author | Koerkamp, B.G. | |
dc.contributor.author | Bañales Asurmendi, Jesús María ![ORCID](/themes/Mirage2//images/orcid_16x16.png) | |
dc.contributor.author | Alvaro, D. | |
dc.contributor.author | Valle, J.W. | |
dc.contributor.author | Lamarca, A. | |
dc.date.accessioned | 2022-02-10T12:03:27Z | |
dc.date.available | 2022-02-10T12:03:27Z | |
dc.date.issued | 2022-01-27 | |
dc.identifier.citation | Esmo Open 7(1) : (2022) // Article ID 100377 | es_ES |
dc.identifier.issn | 2059-7029 | |
dc.identifier.uri | http://hdl.handle.net/10810/55417 | |
dc.description.abstract | BACKGROUND: Cholangiocarcinomas (CCAs) are a rare group of malignancies characterized by dismal prognosis. There are currently no standardized guidelines for multidisciplinary teams (MDTs) in CCAs.
MATERIAL AND METHODS: An online survey was built with the aim of defining the current practice of MDTs in CCAs and identifying possible areas of improvement, providing minimum standards of practice for an ideal CCA MDT. Analysis of the replies regarding current and ideal MDT practice was carried out by calculating weighted average (WA) of likelihood of every item. The survey was shared with members of the European Network for the Study of Cholangiocarcinoma and other medical centers with expertise in biliary tract cancer part of the EURO-CHOLANGIO-NET (European Cholangiocarcinoma Network: https://eurocholangionet.eu/) COST Action CA18122 initiative.
RESULTS: The role of the MDT coordinator was a recognized priority in an ideal well-functioning MDT (WA 3.31/4), together with providing minimum clinical information before the meeting to secure adequate case preparation (WA 3.54/4). Optimal frequency of MDT meetings was weekly according to 76.92% of the participants; 73.06% believed that ideally all newly diagnosed patients and each new treatment should be discussed, although that happened only in less than half of the MDTs (46.15%) in current practice. Most participants stated that they always (46.15%) or often (50.00%) used guidelines, mainly international (61.00%) (European and American), followed by national/local (39.00%). We defined the ideal setup of a CCA MDT, identifying specialists whose presence is mandatory with WA >3.0 (oncologist, clinician responsible for patient's care, surgeon, diagnostic and interventional radiologist, hepatologist, pathologist, endoscopist and gastroenterologist) and those whose presence would be recommended with a WA <3.0 (palliative care, nurse, dietitian, basic researcher, psychologist and social worker).
CONCLUSIONS: Our identified minimum requirements should be taken into account at the time of CCA MDT setup and quality assessment. | es_ES |
dc.description.sponsorship | MC participated as mentee to the Euro-Cholangio-Net
Mentorship Program of EURO-CHOLANGIO-NET COST Ac-
tion CA18122, as a medical resident of gastroenterology in
Sapienza University of Rome. AL received funding from The
Christie Charity and the European Union’s Horizon 2020 Research and Innovation Programme [grant number
825510, ESCALON]; this article/publication is based upon
work from COST Action European Cholangiocarcinoma
Network, supported by COST (European Cooperation in
Science and Technology; www.cost.eu), a funding agency for
research and innovation networks. JB was funded by
Spanish Carlos III Health Institute (ISCIII) [Miguel Servet
Program grant numbers CON14/00129 and CPII19/00008];
CIBERehd (ISCIII); Department of Health of the Basque
Country [grant number 2017111010]; BIOEF (Basque Foun-
dation for Innovation and Health Research: EiTB Maratoia
BIO15/CA/016/BD); ‘Fundación Científica de la Asociación
Española Contra el Cáncer’ (AECC Scientific Foundation);
and the European Union’s Horizon 2020 Research and
Innovation Program [grant number 825510, ESCALON]. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/825510 | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.subject | Europe | es_ES |
dc.subject | cholangiocarcinoma | es_ES |
dc.subject | current practice | es_ES |
dc.subject | multidisciplinary team | es_ES |
dc.subject | survey | es_ES |
dc.title | Setup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | 2022 The Authors. Published by Elsevier Ltd on behalf of Eu-
ropean Society for Medical Oncology. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ | es_ES |
dc.rights.holder | Atribución-NoComercial-SinDerivadas 3.0 España | * |
dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S2059702921003392?via%3Dihub | es_ES |
dc.identifier.doi | 10.1016/j.esmoop.2021.100377 | |
dc.contributor.funder | European Commission | |